Department of Therapeutic Radiology, University of Minnesota, 420 Delaware Street SE, Mayo Mail Code 494, Minneapolis, MN 55455, USA.
Calcif Tissue Int. 2013 Apr;92(4):372-84. doi: 10.1007/s00223-012-9688-0. Epub 2013 Jan 12.
Our purpose was to characterize changes in bone remodeling associated with localized radiation that models therapeutic cancer treatment in ovary-intact (I) and ovariectomized (OVX) mice and to evaluate the influence of radiation on the pattern of bone mineral remodeling. Young adult, female BALB/c mice, I and OVX, were used (n = 71). All mice were intravenously injected with 15 μCi (45)Ca. Thirty days post-(45)Ca administration, the hind limbs of 17 mice were exposed to a single dose of 16 Gy radiation (R). The time course of (45)Ca excretion, serum CTx and osteocalcin markers, and cancellous bone volume fraction (BV/TV) and cortical thickness (Ct.Th) of the distal femur were assayed. Cellular activity and dynamic histomorphometry were performed. Irradiation resulted in rapid increases in fecal (45)Ca excretion compared to control groups, indicating increased bone remodeling. CTx increased rapidly after irradiation, followed by an increase in osteocalcin concentration. BV/TV decreased in the I mice following irradiation. Ct.Th increased in the OVX groups following irradiation. I+R mice exhibited diminished osteoblast surface, osteoclast number, and mineral apposition. Our murine model showed the systemic effects (via (45)Ca excretion) and local effects (via bone microarchitecture and surface activity) of clinically relevant, therapeutic radiation exposure. The I and OVX murine models have similar (45)Ca excretion but different bone microarchitectural responses. The (45)Ca assay effectively indicates the onset and rate of systemic bone mineral remodeling, providing real-time assessment of changes in bone histomorphometric parameters. Monitoring bone health via a bone mineral marker may help to identify the appropriate time for clinical intervention to preserve skeletal integrity.
我们的目的是描述与局部放射治疗相关的骨重塑变化,这种变化模拟了卵巢完整(I)和卵巢切除(OVX)小鼠的治疗性癌症治疗,并评估放射对骨矿物质重塑模式的影响。使用年轻成年雌性 BALB/c 小鼠(I 和 OVX)(n = 71)。所有小鼠均静脉注射 15 μCi(45)Ca。(45)Ca 给药后 30 天,17 只小鼠的后肢接受单次 16 Gy 照射(R)。测定(45)Ca 排泄、血清 CTx 和骨钙素标志物、以及远端股骨的松质骨体积分数(BV/TV)和皮质厚度(Ct.Th)的时间过程。进行细胞活性和动态组织形态计量学测定。与对照组相比,照射导致粪便(45)Ca 排泄迅速增加,表明骨重塑增加。照射后 CTx 迅速增加,随后骨钙素浓度增加。照射后 I 小鼠的 BV/TV 减少。照射后 OVX 组的 Ct.Th 增加。I+R 小鼠表现出骨细胞表面、破骨细胞数量和矿化沉积率减少。我们的小鼠模型显示了临床相关治疗性辐射暴露的全身效应(通过(45)Ca 排泄)和局部效应(通过骨微结构和表面活性)。I 和 OVX 小鼠模型具有相似的(45)Ca 排泄,但骨微结构反应不同。(45)Ca 测定有效地指示了全身骨矿物质重塑的开始和速率,提供了对骨组织形态计量学参数变化的实时评估。通过骨矿物质标志物监测骨健康可能有助于确定临床干预以维持骨骼完整性的适当时间。